Matrix Metalloproteinase (MMP)-3 Activates MMP-9 Mediated Vascular Smooth Muscle Cell Migration and Neointima Formation in Mice

scientific article published on 30 June 2011

Matrix Metalloproteinase (MMP)-3 Activates MMP-9 Mediated Vascular Smooth Muscle Cell Migration and Neointima Formation in Mice is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1161/ATVBAHA.111.225623
P698PubMed publication ID21719762

P50authorJason Lee JohnsonQ43990039
P2093author name stringAndrew C Newby
Amrita Dwivedi
Sarah J George
Michelle Somerville
P433issue9
P407language of work or nameEnglishQ1860
P921main subjectcell migrationQ189092
P304page(s)e35-44
P577publication date2011-06-30
P1433published inArteriosclerosis, Thrombosis, and Vascular BiologyQ4797542
P1476titleMatrix metalloproteinase (MMP)-3 activates MMP-9 mediated vascular smooth muscle cell migration and neointima formation in mice
P478volume31

Reverse relations

cites work (P2860)
Q3363153817β-Estradiol Ameliorates Tight Junction Disruption via Repression of MMP Transcription
Q35239944Adult vascular wall resident multipotent vascular stem cells, matrix metalloproteinases, and arterial aneurysms
Q39052677Berberine suppresses in vitro migration of human aortic smooth muscle cells through the inhibitions of MMP-2/9, u-PA, AP-1, and NF-κB.
Q55346184Cell Based Therapeutic Approach in Vascular Surgery: Application and Review.
Q58705126Cinnamic aldehyde inhibits vascular smooth muscle cell proliferation and neointimal hyperplasia in Zucker Diabetic Fatty rats
Q34966954Current siRNA targets in atherosclerosis and aortic aneurysm
Q35918360Desiccating Stress-Induced MMP Production and Activity Worsens Wound Healing in Alkali-Burned Corneas
Q36041722Digoxin inhibits PDGF-BB-induced VSMC proliferation and migration through an increase in ILK signaling and attenuates neointima formation following carotid injury
Q41628232Downregulation of Cavin-1 Expression via Increasing Caveolin-1 Degradation Prompts the Proliferation and Migration of Vascular Smooth Muscle Cells in Balloon Injury-Induced Neointimal Hyperplasia
Q92754538Epigenetic Regulation of Vascular Smooth Muscle Cells by Histone H3 Lysine 9 Dimethylation Attenuates Target Gene-Induction by Inflammatory Signaling
Q30429015Genetic inactivation of IL-1 signaling enhances atherosclerotic plaque instability and reduces outward vessel remodeling in advanced atherosclerosis in mice
Q58581510Genomic and Transcriptomic Analysis of Hypercholesterolemic Rabbits: Progress and Perspectives
Q36326783IL-1 Signaling Is Critically Required in Stromal Cells in Kawasaki Disease Vasculitis Mouse Model: Role of Both IL-1α and IL-1β
Q34335737IL-1beta signals through the EGF receptor and activates Egr-1 through MMP-ADAM.
Q91867240Immune and Smooth Muscle Cells Interactions in Atherosclerosis: How to Target a Breaking Bad Dialogue?
Q43070812Impact of losartan and angiotensin II on the expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in rat vascular smooth muscle cells
Q37694833Increased phosphorylation of eIF2α in chronic myeloid leukemia cells stimulates secretion of matrix modifying enzymes
Q50450346Inhibition of Smooth Muscle β-Catenin Hinders Neointima Formation After Vascular Injury.
Q38947762Involvement of Angiotensin II Type 1 and 2 Receptors in Gelatinase Regulation in Human Carotid Atheroma in vitro.
Q35721623K Domain CR9 of Low Density Lipoprotein (LDL) Receptor-related Protein 1 (LRP1) Is Critical for Aggregated LDL-induced Foam Cell Formation from Human Vascular Smooth Muscle Cells
Q95840421Kawasaki disease: pathophysiology and insights from mouse models
Q127297872LncRNA NEXN-AS1 attenuates proliferation and migration of vascular smooth muscle cells through sponging miR-33a/b
Q47886411Matrix Metalloproteinase-9 Mediates the Deleterious Effects of α2-Antiplasmin on Blood-Brain Barrier Breakdown and Ischemic Brain Injury in Experimental Stroke
Q26741827Matrix Metalloproteinases in Non-Neoplastic Disorders
Q37983293Matrix metalloproteinase inhibition therapy for vascular diseases
Q41879259Matrix metalloproteinase-9 deletion is associated with decreased mid-term vein wall fibrosis in experimental stasis DVT
Q41888223Matrix metalloproteinases are possible targets in monocrotaline-induced pulmonary hypertension: investigation of anti-remodeling effects of alagebrium and everolimus
Q35161646Matrix metalloproteinases in atherosclerosis: role of nitric oxide, hydrogen sulfide, homocysteine, and polymorphisms
Q36960275Matrix metalloproteinases: inflammatory regulators of cell behaviors in vascular formation and remodeling
Q37080846Mechanisms of Healing in Coiled Intracranial Aneurysms: A Review of the Literature
Q27026468Mechanisms of the inward remodeling process in resistance vessels: is the actin cytoskeleton involved?
Q36284016Microbial carriage state of peripheral blood dendritic cells (DCs) in chronic periodontitis influences DC differentiation, atherogenic potential.
Q38871902Multidimensional Contribution of Matrix Metalloproteinases to Atherosclerotic Plaque Vulnerability: Multiple Mechanisms of Inhibition to Promote Stability
Q43245098Nitro-oxidative stress, VEGF and MMP-9 in patients with cirrhotic and non-cirrhotic portal hypertension
Q88938326Notch2 and Proteomic Signatures in Mouse Neointimal Lesion Formation
Q97875464Overexpression of MicroRNA-340-5p Inhibits Pulmonary Arterial Hypertension Induced by APE by Downregulating IL-1β and IL-6
Q35803389Overexpression of mimecan in human aortic smooth muscle cells inhibits cell proliferation and enhances apoptosis and migration
Q28582869Proteomic analysis identifies an NADPH oxidase 1 (Nox1)-mediated role for actin-related protein 2/3 complex subunit 2 (ARPC2) in promoting smooth muscle cell migration
Q38851167Regulation of the Bioavailability of TGF-β and TGF-β-Related Proteins
Q35934069Role of Matrix Metalloproteinases 2 and 9 in Lacrimal Gland Disease in Animal Models of Sjögren's Syndrome
Q36368188Secreted Hsp90 is a novel regulator of the epithelial to mesenchymal transition (EMT) in prostate cancer.
Q35723980Small-nucleic-acid-based therapeutic strategy targeting the transcription factors regulating the vascular inflammation, remodeling and fibrosis in atherosclerosis
Q49551883Smooth Muscle Cell Fate and Plasticity in Atherosclerosis
Q41412833Smooth Muscle Enriched Long Noncoding RNA (SMILR) Regulates Cell Proliferation
Q42084567Tanshinone IIA suppresses the progression of atherosclerosis by inhibiting the apoptosis of vascular smooth muscle cells and the proliferation and migration of macrophages induced by ox-LDL
Q43119936The effect of matrix metalloproteinase 2 and matrix metalloproteinase 2/9 deletion in experimental post-thrombotic vein wall remodeling
Q41892701The role of urokinase plasminogen activator and plasmin activator inhibitor-1 on vein wall remodeling in experimental deep vein thrombosis

Search more.